Retinopathy at baseline and follow-up
| . | Retinopathy at baseline, n (%) . | Retinopathy at follow-up, n (%) . |
|---|---|---|
| No SCR | 93 (72.1) | 65 (50.4) |
| NPSCR | 19 (14.7) | 33 (25.6) |
| PSCR | 17 (13.2) | 31 (24) |
| 1 eye | 6 (4.7) | 10 (7.8) |
| Both eyes | 11 (8.5) | 21 (16.3) |
| Progression of retinopathy | 37 (28.7) |
| . | Retinopathy at baseline, n (%) . | Retinopathy at follow-up, n (%) . |
|---|---|---|
| No SCR | 93 (72.1) | 65 (50.4) |
| NPSCR | 19 (14.7) | 33 (25.6) |
| PSCR | 17 (13.2) | 31 (24) |
| 1 eye | 6 (4.7) | 10 (7.8) |
| Both eyes | 11 (8.5) | 21 (16.3) |
| Progression of retinopathy | 37 (28.7) |